Plexus (NASDAQ:PLXS - Get Free Report) is projected to post its quarterly earnings results after the market closes on Wednesday, April 23rd. Analysts expect Plexus to post earnings of $1.54 per share and revenue of $980.07 million for the quarter. Plexus has set its Q2 2025 guidance at 1.460-1.610 EPS.Persons that wish to register for the company's earnings conference call can do so using this link.
Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. On average, analysts expect Plexus to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.
Plexus Price Performance
NASDAQ:PLXS traded up $0.74 on Friday, reaching $122.66. 141,120 shares of the company's stock traded hands, compared to its average volume of 164,929. The firm has a market cap of $3.32 billion, a PE ratio of 28.46 and a beta of 0.83. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. The stock has a 50-day simple moving average of $127.54 and a 200-day simple moving average of $144.57. Plexus has a 12 month low of $92.72 and a 12 month high of $172.89.
Insider Transactions at Plexus
In other news, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $136.96, for a total transaction of $205,440.00. Following the completion of the sale, the chief executive officer now owns 86,932 shares in the company, valued at approximately $11,906,206.72. This represents a 1.70 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Michael J. Running sold 1,250 shares of the business's stock in a transaction on Friday, February 21st. The stock was sold at an average price of $138.62, for a total value of $173,275.00. Following the transaction, the insider now owns 1,276 shares in the company, valued at approximately $176,879.12. This trade represents a 49.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,958 shares of company stock valued at $2,551,930. 1.76% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on PLXS. Benchmark reissued a "buy" rating and issued a $165.00 target price on shares of Plexus in a report on Wednesday, January 22nd. Stifel Nicolaus began coverage on shares of Plexus in a research report on Tuesday, February 4th. They set a "hold" rating and a $152.00 target price on the stock. Finally, Needham & Company LLC lifted their price target on Plexus from $162.00 to $172.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Plexus currently has an average rating of "Moderate Buy" and an average price target of $163.00.
Check Out Our Latest Research Report on PLXS
About Plexus
(
Get Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.